BackgroundSevere mental illness (SMI) is thought to be associated with lower diet quality
and adverse eating behaviours contributing towards physical health disparities. A rigorous …

Objective: The objective is to summarise recent findings from the 2010 Australian Survey of
High Impact Psychosis (SHIP) and examine their implications for future policy and planning …

Background Currently there is no first-line treatment recommended for the negative
symptoms of schizophrenia. Psychosocial and behavioural interventions are widely used to …

Background A high prevalence of metabolic syndrome and its components in patients with
psychotic disorders may increase the risk for cardiovascular diseases. Unfortunately …

Medication with neuroleptics has been associated with adipose tissue dysfunctions and, in
particular, with increased visceral fat amount. However, several studies suggested that …

Schizophrenia is a complex mental illness affecting the normal functioning of the brain,
interfering with the ability to think, feel and act. It can be conceptualised as a syndrome of …

Many psychopathological symptoms, including schizophrenia, can be associated with
magnesium metabolism disturbances. In the literature, contradictory data exist regarding …

The present study aimed to evaluate the 12-month effectiveness of a real-world weight loss
transdiagnostic intervention in overweight/obese participants affected by mental disorders …

Primary care management of cardiovascular risk for people with severe mental illnesses: the
Primrose research programme includin Page 1 PROGRAMME GRANTS FOR APPLIED …

Objetivo Realizar uma revisão de escopo a respeito dos efeitos adversos cardiovasculares
e metabólicos associados ao uso de antipsicóticos em pessoas com o diagnóstico de …